Chronic pain affects 1B+ people, yet non-addictive therapies remain scarce. Neomera BioLab is building a biology-first, AI-accelerated drug-discovery platform for non-opioid pain treatments. Led by @YuRebeccaMiao @eleenlu — Stanford alumni with experience across Bain Capital and top pharma R&D. 🎬 Catch Rebecca at EASY Residency S2 Demo Day.